These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 3220102)

  • 1. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
    Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
    Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the alternative pathway of complement by human serum IgA.
    Hiemstra PS; Gorter A; Stuurman ME; Van Es LA; Daha MR
    Eur J Immunol; 1987 Mar; 17(3):321-6. PubMed ID: 3569402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune complex modulation by plasma proteins. With special reference to the complement system and autoimmune diseases.
    Baatrup G
    Dan Med Bull; 1989 Oct; 36(5):443-63. PubMed ID: 2530063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.
    Schena PF; Pastore A; Sinico RA; Montinaro V; Fornasieri A
    J Immunol; 1988 Jul; 141(1):125-30. PubMed ID: 3379302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes.
    Zhang W; Lachmann PJ
    Immunology; 1994 Jan; 81(1):137-41. PubMed ID: 8132210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of immune complexes by the classical pathway.
    Whaley K; Ahmed AE
    Behring Inst Mitt; 1989 Jul; (84):111-20. PubMed ID: 2529842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK; Holme E; Hamilton E; Whaley K
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of rat complement by soluble and insoluble immune complexes of rat IgA.
    Rits M; Hiemstra PS; Bazin H; van Es LA; Daha M; Vaerman JP
    Monogr Allergy; 1988; 24():129-33. PubMed ID: 3362139
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of C3 with antigen-antibody complexes in the process of solubilization of immune precipitates.
    Takata Y; Tamura N; Fujita T
    J Immunol; 1984 May; 132(5):2531-7. PubMed ID: 6232320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rat C3 conversion by rat anti-2,4,dinitrophenyl (DNP) hapten IgA immune precipitates.
    Rits M; Kints JP; Bazin H; Vaerman JP
    Scand J Immunol; 1987 Apr; 25(4):359-66. PubMed ID: 3576132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of immune precipitation by complement.
    Hong K; Takata Y; Sayama K; Kozono H; Takeda J; Nakano Y; Kinoshita T; Inoue K
    J Immunol; 1984 Sep; 133(3):1464-70. PubMed ID: 6747294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble and insoluble immune complexes activate human neutrophil NADPH oxidase by distinct Fc gamma receptor-specific mechanisms.
    Crockett-Torabi E; Fantone JC
    J Immunol; 1990 Nov; 145(9):3026-32. PubMed ID: 2170530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monomeric immunoglobulin A protects glomerulus against polymeric immunoglobulin A immune complex in experimental immunoglobulin A nephropathy.
    Chen A; Sheu LF; Ding SL; Lee WH
    Lab Invest; 1996 Apr; 74(4):737-46. PubMed ID: 8606484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation of rat IgM to IgG hybridoma isotype switch variants and analysis of the efficiency of rat Ig in complement activation.
    Pluschke G; Bordmann G; Daoudaki ME; Lambris JD; Achtman M; Neibert M
    Eur J Immunol; 1989 Jan; 19(1):131-5. PubMed ID: 2646134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes.
    Schneiderman RD; Lint TF; Knight KL
    J Immunol; 1990 Jul; 145(1):233-7. PubMed ID: 2358675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of complement activation by human IgA immune complexes.
    Imai H; Chen A; Wyatt RJ; Rifai A
    Clin Exp Immunol; 1988 Sep; 73(3):479-83. PubMed ID: 3061690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes.
    Miletic VD; Hester CG; Frank MM
    J Immunol; 1996 Jan; 156(2):749-57. PubMed ID: 8543829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement depletion abolishes IgA-mediated glomerular inflammation in rats.
    Stad RK; van Gijlswijk-Janssen DJ; van Es LA; Daha MR
    Exp Nephrol; 1994; 2(3):182-9. PubMed ID: 7922271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relative inefficiency of terminal complement activation.
    Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
    J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rat polymeric IgA binds C1q, but does not activate C1.
    Hiemstra PS; Rits M; Gorter A; Stuurman ME; Hoekzema R; Bazin H; Vaerman JP; van Es LA; Daha MR
    Mol Immunol; 1990 Sep; 27(9):867-74. PubMed ID: 2215479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.